ENTPD1 and lymphoma: An increased frequency of CD4+CD39+Tregs has been reported in tumor-infiltrating T cells in lymphoma patients.[38] Similar to CD39+Tregs in the peripheral blood, half of these cells are CD25+FoxP3+ active suppressor cells.